Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry.
Journal Information
Full Title: Nucl Med Commun
Abbreviation: Nucl Med Commun
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nuclear Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest C.M.L.v.H.: Consultant fees for participation in advisory boards (not personal, but on behalf of the institute): Bayer, Bristol-Myers Squibb, Ipsen, MSD, Regeneron, and Philips Molecular Pathway Diagnostics. Research grants: Astra Zeneca, Bristol-Myers Squibb, MSD, Merck, Ipsen, Novartis, and Sanofi. J.N.: Consultation for CURIUM, IIT Novartis and ABX. For the remaining authors, there are no conflicts of interest."
"This work was supported by the Dutch Cancer Society (KWF), the Dutch Prostate cancer foundation, and the Radboud Oncology Foundation. This work was supported by the Dutch Cancer Society (KWF), the Dutch Prostate cancer foundation, and the Radboud Oncology Foundation."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025